Michael Burgess actually said...

"I do think that ONC has a unique perspective on these HIT issues, and along with input from the FDA and from stakeholders that Congress can find a path forward on what a framework would look like."

"Inaction is not an option on this issue. However, we must do so in a way that encourages the development of innovative technologies."

"I am grateful to the chairman for holding this hearing, grateful to our panel for presenting to us today."

"From the newest means to detect and diagnose conditions, to the cures and diseases that once were thought untreatable, innovation has led the way to bettering the lives of patients."